Evidence map›Paper›PMID 34607450›Full record

ArticlemBio2021

CYP51 Paralogue Structure Is Associated with Intrinsic Azole Resistance in Fungi.

N Van Rhijn, M Bromley, M Richardson, P Bowyer

Abstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Comparison and Analysis of Resistance Differences inJournal of fungi (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Complete genome sequences of agricultural azole-resistantMicrobiology resource announcements · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Azole Resistance andJournal of fungi (Basel, Switzerland) · 2022
    Article
  12. Journal of fungi (Basel, Switzerland) · 2022
    Article
  13. The Gβ-like ProteinJournal of fungi (Basel, Switzerland) · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

N Van RhijnManchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, The University of Manchestergrid.5379.8, Manchester, United Kingdom.ORCID 0000-0001-6722-2757
M BromleyManchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, The University of Manchestergrid.5379.8, Manchester, United Kingdom.
M RichardsonManchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, The University of Manchestergrid.5379.8, Manchester, United Kingdom.
P BowyerManchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, The University of Manchestergrid.5379.8, Manchester, United Kingdom.

Funding

Elevated gene transcription of the cyp51A gene is essential for azole drug resistance in Aspergillus fumigatusR01AI143198 · NIAID · UNIVERSITY OF IOWA · PI W Scott Moye-Rowley · 2019 to 2026
$3.9M
Medical Research Council MR/M02010X/1NIAID NIH HHS R01 AI143198Wellcome TrustWellcome Trust 208396/Z/17/ZWellcome Trust 219551/Z/19/Z
6 · The paper itself

Abstract

Azoles are the most commonly used clinical antifungal therapy and also play an important role in control of plant pathogens. Intrinsic resistance to the azole class of fungicides, which target lanosterol demethylase (CYP51), is observed in many fungal species; however, the mechanisms underpinning this phenomenon are unknown. In this study, 5 azole-resistant

Indexed as

Antifungal AgentsAspergillosisAspergillusAspergillus fumigatusAzolesDrug Resistance, FungalFungal ProteinsFungiFungicides, IndustrialHumansMicrobial Sensitivity TestsMycosesSterol 14-DemethylaseAntifungal AgentsAzolesFungal ProteinsFungicides, IndustrialSterol 14-Demethylaseantifungal agentsantifungal resistanceAspergilluscrypticCYP51paralogyPenicillium

Identifiers

PMID34607450
PMCPMC8546618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.